Financials
- Market Capitalization 249.73 M
- Employee 57
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.18
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3371 | SABS SAB Biotherapeutics, Inc. - Common Stock | 2.83 USD | -5.03% | -9.29% | -17.25% | +23.58% | 257.49 M USD | ||
| 3380 | FATE Fate Therapeutics, Inc. - Common Stock | 2.13 USD | -2.29% | -12.70% | -7.39% | +54.35% | 255.22 M USD | ||
| 3391 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 3.04 USD | -5.88% | -11.37% | -29.47% | -62.33% | 249.42 M USD | ||
| 3392 | ACIU AC Immune SA - Common Stock | 2.45 USD | -2.00% | -9.93% | -10.26% | -28.57% | 249.27 M USD |